Medtronic plc. ($MDT) Stock Forecast: Up 5.4% Today

What is Medtronic plc.?

Medtronic (MDT) is a leading medical technology company recognized for its innovative healthcare solutions and strong financial performance. The stock showed bullish movement today, reflecting positive investor sentiment.

Why is Medtronic plc. going up?

MDT stock is up 5.4% on Jun 3, 2026 19:06

• Medtronic (MDT) stock demonstrated a bullish trend today, potentially influenced by several factors:
• Strong Q4 2026 earnings performance surpassing revenue expectations, highlighting the company's robust financial position and growth potential.
• Submission of 510(k) filings for expanding the Hugo™ robotic-assisted surgery system into new specialties, signaling a focus on innovation and market growth.
• Mizuho's reduced price target, coupled with a maintained Outperform rating, might have been seen as an opportunity by investors, particularly in light of Medtronic being deemed undervalued by InvestingPro.
• Discussions on earning $500 per month from Medtronic stock dividends could have enticed investors seeking income, potentially contributing to the bullish movement.

MDT Price Chart

MDT Technical Analysis

MDT News

ISRG Falls 11% in a Month: Is a Reversal on the Cards for the Stock?

Intuitive Surgical (ISRG) shares have dropped 11% in the past month despite strong Q1 2026 results, driven by broader market concerns rather than operational performance. The article explores catalysts for a potential recovery, including the da Vinci 5 platform, a robust digital ecosystem, international expansion, and emerging growth platforms. Despite premium valuation and competition, the pullback is seen as a buying opportunity given strong fundamentals and a Zacks Rank #2 (Buy) rating.

https://www.tradingview.com/news/zacks:a52982d7c094b:0-isrg-falls-11-in-a-month-is-a-reversal-on-the-cards-for-the-stock/

Private Payrolls Increased More Than Expected

The U.S. labor market showed significant improvement with private payrolls increasing more than expected in May, reaching +122K new jobs. This follows an uptick in April's JOLTS report to 7.6 million job openings. Notably, small businesses led job growth, and sectors like Education/Healthcare and Trade/Transportation/Utilities saw strong gains. Additionally, Macy's and Medtronic reported impressive Q1 earnings, beating estimates.

https://www.tradingview.com/news/zacks:252214906094b:0-private-payrolls-increased-more-than-expected/

How To Earn $500 A Month From Medtronic Stock After Q4 Earnings

Medtronic (NYSE: MDT) reported strong Q4 2026 earnings, surpassing revenue estimates. The article details how investors can earn $500 monthly from Medtronic's dividend, which has a 3.83% yield, requiring an investment of approximately $155,833 or 2,113 shares. It also explains how dividend yield is calculated and affected by stock price and dividend payment fluctuations.

https://www.benzinga.com/markets/earnings/26/06/52967579/how-to-earn-500-a-month-from-medtronic-stock-after-q4-earnings

Mizuho lowers Medtronic stock price target to $100 on valuation

Mizuho has reduced its price target for Medtronic (NYSE: MDT) to $100 from $120, while maintaining an Outperform rating, citing current valuation levels below historical averages. The firm anticipates accelerated growth for Medtronic exiting fiscal year 2027, driven by new product launches and expects a 5% organic sales growth and $6.10 adjusted EPS for FY2027. Despite the lowered price target, InvestingPro analysis suggests Medtronic is undervalued, highlighting its 50-year dividend payment streak and 3.85% yield.

https://www.investing.com/news/analyst-ratings/mizuho-lowers-medtronic-stock-price-target-to-100-on-valuation-93CH-4724001

Medtronic submits 510(k) filings to expand Hugo™ robotic-assisted surgery system into general and gynecologic specialties in the United States

Medtronic (NYSE: MDT) has submitted 510(k) filings to the FDA to expand the indications for its Hugo™ robotic-assisted surgery (RAS) system into general and gynecologic surgical specialties in the United States. The company also announced a 510(k) filing for the LigaSure™ RAS Maryland instrument for use with Hugo, and received 510(k) clearance for ProGrip™ Advanced self-gripping polypropylene mesh for robotic-assisted ventral hernia repair. These developments aim to broaden the system's clinical applicability and enhance its capabilities in high-volume surgical areas.

https://news.medtronic.com/2026-06-03-Medtronic-submits-510-k-filings-to-expand-Hugo-TM-robotic-assisted-surgery-system-into-general-and-gynecologic-specialties-in-the-United-States

Trending Today

Cardano ($ADA) Crypto Forecast: Down 5.1% Today

Ethereum ($ETH) Crypto Forecast: Down 5.8% Today

Newell Brands Inc. ($NWL) Stock Forecast: Up 5.7% Today

DocuSign Inc. ($DOCU) Stock Forecast: Down 5.0% Today

Salesforce.com Inc ($CRM) Stock Forecast: Down 5.0% Today

Moderna Inc. ($MRNA) Stock Forecast: Up 7.8% Today

Coinbase Global Inc. ($COIN) Stock Forecast: Down 6.0% Today

Honeywell International Inc. ($HON) Stock Forecast: Down 5.2% Today

Palantir Technologies Inc ($PLTR) Stock Forecast: Down 6.4% Today

Texas Roadhouse Inc. ($TXRH) Stock Forecast: Down 4.0% Today

Medtronic plc. Price History

04.01.2026 - MDT Stock was down 2.8%

• The retirement announcement of Medtronic's Senior Vice President and President of Structural Heart and Aortic, Nina Goodheart, has led to uncertainty among investors regarding future leadership and strategic direction in that segment, resulting in a bearish movement in the stock.
• Despite Medtronic's acquisition plans for CathWorks and the positive news of institutional investors increasing their stakes in the company, the market reaction may be linked to concerns about the potential impact of leadership changes on key product lines.
• The projected growth potential in the continuous glucose monitoring devices market, with a estimated market size of US$10.72 billion by 2033, might be overshadowed by worries about the immediate leadership transition within Medtronic's structural heart division.
• The current bearish movement in Medtronic's stock may stem from a combination of profit-taking following recent positive developments and investor caution regarding upcoming changes in crucial leadership positions within the company.

05.00.2026 - MDT Stock was up 0.7%

• Medtronic PLC (MDT) experienced a strong bullish movement today.
• The company exceeded Q3 earnings estimates, reporting $1.36 EPS and $8.96 billion in revenue, and provided a positive forecast for FY26 EPS.
• The market movement could be attributed to a firm lowering its stake in MDT by 9.9% in Q3, potentially signaling confidence in the company's future performance.
• The overall positive sentiment towards AI-powered medical stocks, including MDT, as highlighted in discussions focusing on the integration of AI in the medical sector, could have also contributed to the bullish movement.

03.05.2026 - MDT Stock was up 5.4%

• Medtronic (MDT) stock demonstrated a bullish trend today, potentially influenced by several factors:
• Strong Q4 2026 earnings performance surpassing revenue expectations, highlighting the company's robust financial position and growth potential.
• Submission of 510(k) filings for expanding the Hugo™ robotic-assisted surgery system into new specialties, signaling a focus on innovation and market growth.
• Mizuho's reduced price target, coupled with a maintained Outperform rating, might have been seen as an opportunity by investors, particularly in light of Medtronic being deemed undervalued by InvestingPro.
• Discussions on earning $500 per month from Medtronic stock dividends could have enticed investors seeking income, potentially contributing to the bullish movement.

18.10.2025 - MDT Stock was up 5.1%

• Following its Q2 earnings, Medtronic (MDT) saw a strong upward trend in its stock value, buoyed by exceeding earnings expectations and showcasing robust growth in the Cardiovascular segment.
• The company's revised 2026 outlook also bolstered investors' confidence, leading to a rise in the stock price.
• Analysts' positive forecast adjustments prior to the earnings announcement foreshadowed a strong performance, paving the way for the stock's climb post-earnings.
• Market response indicates investor trust in Medtronic's financial stability and growth opportunities, driving the stock's ascent as optimism for future success grows.

18.10.2025 - MDT Stock was up 6.0%

• Medtronic (MDT) surpassed earnings and revenue forecasts for the second quarter, demonstrating strong financial results.
• Analysts raised their projections before the earnings announcement, indicating confidence in the company's expansion opportunities.
• The optimistic projections for Medtronic's Cardiovascular unit and Diabetes segment potentially influenced the stock's upward movement, highlighting potential growth in these key sectors.
• Overall, investors reacted favorably to Medtronic's robust performance and promising future prospects, leading the stock to climb higher.

03.05.2026 - MDT Stock was up 6.0%

• The submission of 510(k) filings to expand the Hugo™ robotic-assisted surgery system and the clearance for ProGrip™ Advanced mesh demonstrate Medtronic's dedication to enhancing its product portfolio and reaching new markets.
• The Q4 2026 financial results showed a mix of performance, surpassing revenue expectations with significant growth in the Cardiovascular segment, which enhanced investor confidence in Medtronic's present and future prospects.
• Despite a slight initial stock decrease due to earnings guidance slightly below consensus for fiscal year 2027, the overall optimism regarding Medtronic's investments in cardiac ablation technologies and robust revenue growth in fiscal 2026 likely drove the positive movement witnessed today.

03.05.2026 - MDT Stock was up 5.1%

• Medtronic's positive movement today is a result of its impressive Q4 2026 earnings, exceeding revenue projections and achieving the highest annual revenue growth in ten years.
• The company's expansion of the Hugo™ robotic-assisted surgery system into new specialties through 510(k) filings highlights its dedication to innovation and widening market presence.
• Investors seeking stable returns in a volatile market have likely been attracted by Medtronic's consistent dividend payments, boasting a 3.83% yield.
• Medtronic's focus on enriching its product offerings, strategic acquisitions, and robust financial performance have collectively fostered favorable market sentiment and the upward trajectory of its stock.